Unknown

Dataset Information

0

The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery.


ABSTRACT: Nanocarriers (NC) are very promising tools for cancer immunotherapy. Whereas conventional vaccines are based on the administration of an antigen and an adjuvant in an independent fashion, nanovaccines can facilitate cell-specific co-delivery of antigen and adjuvant. Furthermore, nanovaccines can be decorated on their surface with molecules that facilitate target-specific antigen delivery to certain antigen-presenting cell types or tumor cells. However, the target cell-specific uptake of nanovaccines is highly dependent on the modifications of the nanocarrier itself. One of these is the formation of a protein corona around NC after in vivo administration, which may potently affect cell-specific targeting and uptake of the NC. Understanding the formation and composition of the protein corona is, therefore, of major importance for the use of nanocarriers in vaccine approaches. This Mini Review will give a short overview of potential non-specific interactions of NC with body fluids or cell surfaces that need to be considered for the design of NC vaccines for immunotherapy of cancer.

SUBMITTER: Bros M 

PROVIDER: S-EPMC6082927 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery.

Bros Matthias M   Nuhn Lutz L   Simon Johanna J   Moll Lorna L   Mailänder Volker V   Landfester Katharina K   Grabbe Stephan S  

Frontiers in immunology 20180802


Nanocarriers (NC) are very promising tools for cancer immunotherapy. Whereas conventional vaccines are based on the administration of an antigen and an adjuvant in an independent fashion, nanovaccines can facilitate cell-specific co-delivery of antigen and adjuvant. Furthermore, nanovaccines can be decorated on their surface with molecules that facilitate target-specific antigen delivery to certain antigen-presenting cell types or tumor cells. However, the target cell-specific uptake of nanovacc  ...[more]

Similar Datasets

| S-EPMC6687821 | biostudies-literature
| S-EPMC6208370 | biostudies-literature
2022-10-19 | GSE206164 | GEO
| S-EPMC10238184 | biostudies-literature
| S-EPMC9322927 | biostudies-literature
| S-EPMC10552659 | biostudies-literature
| S-EPMC5391497 | biostudies-literature
| S-EPMC4729864 | biostudies-literature
| S-EPMC8675876 | biostudies-literature
| PRJNA849515 | ENA